Prevalence of KIT D816V Mutations in Non-Advanced Systemic Mastocytosis

Lindsay Rein, MD, and Frederick Lansigan, MD, explore the prevalence and clinical significance of KIT D816V mutations in non-advanced systemic mastocytosis. They explain how mutation status influences diagnosis, prognostication, and emerging treatment strategies. Rein and Lansigan also discuss testing considerations and how molecular insights are reshaping disease characterization.